Tirzepatide vs Semaglutide: Temecula Medical Group: Primary Care Clinic, Direct Primary Care (Concierge Medicine), & Wellness Clinic Naltrexone Vs Naloxone: Opioid Blocking Medications The U.S. Food and Drug Administration approved Eli Lilly's GLP 1 pill, the company said, a major milestone for the Indianapolis based drugmaker and one that will test the market for new weight loss medications. Bupropion: The Poor Man's Cocaine? A Case Report ACOEP RSO A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes